These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 25273840)

  • 1. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
    Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
    Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
    Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
    Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.
    Waldron JA; Tack DC; Ritchey LE; Gillen SL; Wilczynska A; Turro E; Bevilacqua PC; Assmann SM; Bushell M; Le Quesne J
    Genome Biol; 2019 Dec; 20(1):300. PubMed ID: 31888698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eIF4B stimulates translation of long mRNAs with structured 5' UTRs and low closed-loop potential but weak dependence on eIF4G.
    Sen ND; Zhou F; Harris MS; Ingolia NT; Hinnebusch AG
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10464-72. PubMed ID: 27601676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
    Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
    Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.
    Singh K; Lin J; Lecomte N; Mohan P; Gokce A; Sanghvi VR; Jiang M; Grbovic-Huezo O; Burčul A; Stark SG; Romesser PB; Chang Q; Melchor JP; Beyer RK; Duggan M; Fukase Y; Yang G; Ouerfelli O; Viale A; de Stanchina E; Stamford AW; Meinke PT; Rätsch G; Leach SD; Ouyang Z; Wendel HG
    Cancer Res; 2021 Apr; 81(8):2002-2014. PubMed ID: 33632898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
    Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
    Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting RNA helicases in cancer: The translation trap.
    Heerma van Voss MR; van Diest PJ; Raman V
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):510-520. PubMed ID: 28965870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the eIF4A RNA helicase as an anti-neoplastic approach.
    Chu J; Pelletier J
    Biochim Biophys Acta; 2015 Jul; 1849(7):781-91. PubMed ID: 25234619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
    Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
    Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein.
    Jin C; Rajabi H; Rodrigo CM; Porco JA; Kufe D
    Oncogene; 2013 Apr; 32(17):2179-88. PubMed ID: 22689062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
    Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.
    Raza F; Waldron JA; Quesne JL
    Biochem Soc Trans; 2015 Dec; 43(6):1227-33. PubMed ID: 26614665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A.
    Thompson PA; Eam B; Young NP; Fish S; Chen J; Barrera M; Howard H; Sung E; Parra A; Staunton J; Chiang GG; Gerson-Gurwitz A; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Xiang A; Nilewski C; Packard GK; Michels T; Tran C; Sprengeler PA; Ernst JT; Reich SH; Webster KR
    Mol Cancer Ther; 2021 Jan; 20(1):26-36. PubMed ID: 33037136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling between the DEAD-box RNA helicases Ded1p and eIF4A.
    Gao Z; Putnam AA; Bowers HA; Guenther UP; Ye X; Kindsfather A; Hilliker AK; Jankowsky E
    Elife; 2016 Aug; 5():. PubMed ID: 27494274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.
    Chu J; Galicia-Vázquez G; Cencic R; Mills JR; Katigbak A; Porco JA; Pelletier J
    Cell Rep; 2016 Jun; 15(11):2340-7. PubMed ID: 27239032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.
    Bordeleau ME; Robert F; Gerard B; Lindqvist L; Chen SM; Wendel HG; Brem B; Greger H; Lowe SW; Porco JA; Pelletier J
    J Clin Invest; 2008 Jul; 118(7):2651-60. PubMed ID: 18551192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
    Iwasaki S; Floor SN; Ingolia NT
    Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.
    Bordeleau ME; Matthews J; Wojnar JM; Lindqvist L; Novac O; Jankowsky E; Sonenberg N; Northcote P; Teesdale-Spittle P; Pelletier J
    Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10460-5. PubMed ID: 16030146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide A.
    Chen M; Asanuma M; Takahashi M; Shichino Y; Mito M; Fujiwara K; Saito H; Floor SN; Ingolia NT; Sodeoka M; Dodo K; Ito T; Iwasaki S
    Cell Chem Biol; 2021 Apr; 28(4):475-486.e8. PubMed ID: 33296667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.